TRADENAME: MAVERICK

ACTIVE PRINCIPLE: Pazopanib

PRESENTATIONS FOR SALE:

200 mg Comp. X 30

400 mg Comp. X 30

THERAPEUTIC ACTION: Antineoplastic agent,

Inhibitor proteininase.